In the present prospective study, the differences in first-phase insulin secretion and the effect of ITT on the improvement of β-cell function were investigated and compared in newly diagnosed T2DM patients with or without a FH of diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.